RhumbLine Advisers’s Neuphoria Therapeutics Inc. Common Stock NEUP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $234 | Sell |
33
-382
| -92% | -$2.71K | ﹤0.01% | 4093 |
|
|
2025
Q1 | $2.39K | Sell |
415
-691
| -62% | -$3.98K | ﹤0.01% | 3973 |
|
|
2024
Q4 | $3.79K | Buy |
1,106
+414
| +60% | +$1.42K | ﹤0.01% | 3987 |
|
|
2024
Q3 | $3.61K | Buy |
692
+509
| +278% | +$2.66K | ﹤0.01% | 4017 |
|
|
2024
Q2 | $1.68K | Buy |
183
+74
| +68% | +$680 | ﹤0.01% | 4199 |
|
|
2024
Q1 | $1.34K | Buy |
109
+67
| +160% | +$826 | ﹤0.01% | 4122 |
|
|
2023
Q4 | $757 | Hold |
42
| – | – | ﹤0.01% | 4174 |
|
|
2023
Q3 | $1.36K | Buy |
+42
| New | +$1.36K | ﹤0.01% | 4154 |
|